Terpenoid ID | TKC027192 | |
Cell line | 0 | |
Protein target | 15 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 20 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC027192 | Raji | RAJI; P1-Raji; GM04671 | 70.0 | % | Activity | C27694 | Orphanet_543 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC027192 | P11473 | Vitamin D3 receptor | VDR | 35481 | nM | Potency |
TKC027192 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 29093 | nM | Potency |
TKC027192 | O95398 | Rap guanine nucleotide exchange factor 3 | RAPGEF3 | 56234 | nM | Potency |
TKC027192 | Q962Y6 | Thioredoxin glutathione reductase | TGR | 28184 | nM | Potency |
TKC027192 | Q9UNA4 | DNA polymerase iota | POLI | 100000 | nM | Potency |
TKC027192 | O75496 | Geminin | GMNN | 29093 | nM | Potency |
TKC027192 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 35481 | nM | Potency |
TKC027192 | O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | USP1 | 28184 | nM | Potency |
TKC027192 | P0DTD1 | Replicase polyprotein 1ab | rep | 32 | % | Inhibition |
TKC027192 | P83916 | Chromobox protein homolog 1 | CBX1 | 79433 | nM | Potency |
TKC027192 | P00811 | Beta-lactamase | ampC | 6310 | nM | Potency |
TKC027192 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 14125 | nM | Potency |
TKC027192 | P02791 | Ferritin light chain | FTL | 28184 | nM | Potency |
TKC027192 | Q92830 | Histone acetyltransferase KAT2A | KAT2A | 39811 | nM | Potency |
TKC027192 | Q9Y253 | DNA polymerase eta | POLH | 50119 | nM | Potency |
TKC027192 | O95342 | Bile salt export pump | ABCB11 | >1000000 | nM | IC50 |
TKC027192 | P25094 | Peripheral myelin protein 22 | Pmp22 | 16137 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
P11473 | VDR_HUMAN | Chronic kidney disease [ICD-11: GB61] |
P11473 | VDR_HUMAN | Hair/hair growth developmental defect [ICD-11: LC30] |
P11473 | VDR_HUMAN | Hyper-parathyroidism [ICD-11: 5A51] |
P11473 | VDR_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
P11473 | VDR_HUMAN | Mineral deficiency [ICD-11: 5B5K] |
P11473 | VDR_HUMAN | Psoriasis [ICD-11: EA90] |
P11473 | VDR_HUMAN | Vitamin deficiency [ICD-11: 5B55-5B5F] |
P11473 | VDR_HUMAN | Low bone mass disorder [ICD-11: FB83] |
P11473 | VDR_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P11473 | VDR_HUMAN | Prostate cancer [ICD-11: 2C82] |
P11473 | VDR_HUMAN | Prostate disease [ICD-11: GA91] |
P11473 | VDR_HUMAN | Abnormal micturition [ICD-11: MF50] |
P11473 | VDR_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P11473 | VDR_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P11473 | VDR_HUMAN | Acne vulgaris [ICD-11: ED80] |
O95398 | RPGF3_HUMAN | Epidermal dysplasias [ICD-11: EK90] |
O94782 | UBP1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |